Invitae and Myriad Step Into Crowded Market with Noninvasive Prenatal Screening Tests

Feb 21, 2019

|

Premium

This article has been updated with additional pricing information from Invitae.

NEW YORK (GenomeWeb) – In an effort to broaden their offerings in the reproductive health market, Myriad Genetics and Invitae last week both announced new or expanded genetic noninvasive prenatal screening tests for fetal chromosomal aneuploidies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

Gene Not Present

Retraction Watch reports that a paper was pulled because it refers to a gene that doesn't exist in mice.

From the Brink?

Researchers were able to generate fertilized northern white rhinoceros eggs, according to Mashable.

Former Employees Raise Testing Issues

Former Orig3n employees raise concerns about its testing at Bloomberg Businessweek.

PLOS Papers Explore HCC MicroRNAs, PCR-Based Schistosomiasis Diagnostics, More

In PLOS this week: microRNA expression changes in hepatocellular carcinoma, real-time PCR-based approach for diagnosing schistosomiasis, and more.

Featured White Papers

Analytical Validation of the Oncomine Pan-Cancer Cell-Free Assay

Multiplexed Infectious Disease Analysis

A High-Performance Solution Combining CleanPlex OncoZoom Cancer Hotspot Panel and SOPHiA AI for Rapid Characterization of Somatic Mutations

Benchmarking of the Microsart AMP Mycoplasma Kit with Products of Two Other Suppliers

Sep

18

Featured Webinar

Highly Sensitive Structural Variant Detection for Medical Genetics: A Comparison to the Standard of Care

This webinar will outline how a team at Radboud University Medical Center is assessing ultra-long read optical mapping on the Bionano Saphyr system to replace classical cytogenetics approaches in routine testing and for the discovery of novel structural variants with potential scientific, prognostic, or therapeutic value that are missed by standard approaches.

Sep

25

Featured Webinar

Biomarker Evaluation for CAR T-Cell Therapy: Impact on Drug Development

CAR T-cell therapy is an innovative form of immunotherapy that is finding increasing use for the management of blood cancers.

Oct

03

Featured Webinar

Streamlined and High-Precision Cancer Analysis Using an Automated NGS Workflow in the Reference Lab Setting

This webinar will provide an overview of how an international reference laboratory has implemented an automated next-generation sequencing workflow with custom panels for analyzing cancer samples.

Oct

08

Featured Webinar

Integration of Single Cell and Spatially Resolved Methods for Understanding Neurodegeneration in ALS

This webinar will discuss a study that used spatial transcriptomics to gain insight into the molecular mechanisms of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease.

Menu